Pfizer has announced that it will be testing a third dose of its coronavirus vaccine to determine if it will offer better protection against variants of the virus.
“We believe that the third dose will raise the antibody response 10- to 20-fold," Pfizer CEO Albert Bourla said in an interview with NBC News.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Already a print subscriber? Click here to login/register your account
